P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial
Titel:
P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial
Auteur:
Canino, F. Barbolini, M. De Giorgi, U. Dominici, M. Gianni, L. Moscetti, L. Omarini, C. Zamagni, C. Molinaro, A. Antonelli, G. Baglio, F. Martinelli, G. Natalizio, S. Ponzoni, O. Piacentini, F.